Variant report
Variant | nsv1019978 |
---|---|
Chromosome Location | chr5:152278020-152316446 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571077956 | chr5:152279820-152279821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560228321 | chr5:152279839-152279840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143021311 | chr5:152279862-152279863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556488510 | chr5:152279930-152279931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568493328 | chr5:152279947-152279948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs535947691 | chr5:152280003-152280004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554348355 | chr5:152280015-152280016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572580285 | chr5:152280059-152280060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545970906 | chr5:152280071-152280072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs552931326 | chr5:152280123-152280124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7702551 | chr5:152280130-152280131 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs67023410 | chr5:152280135-152280136 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs113946288 | chr5:152280182-152280183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375397998 | chr5:152280200-152280201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs561704159 | chr5:152280209-152280210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs78511121 | chr5:152280210-152280211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs368050351 | chr5:152280254-152280255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs369950901 | chr5:152280320-152280321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558983884 | chr5:152280321-152280322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs570743967 | chr5:152280406-152280407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552711773 | chr5:152280418-152280419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542855274 | chr5:152280492-152280493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537607917 | chr5:152280498-152280499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs74393369 | chr5:152280505-152280506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs568456194 | chr5:152280548-152280549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs148184142 | chr5:152280561-152280562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs114914568 | chr5:152280651-152280652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566148461 | chr5:152280667-152280668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539564678 | chr5:152280683-152280684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182150430 | chr5:152280713-152280714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs376541672 | chr5:152280771-152280772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs546746161 | chr5:152280772-152280773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs117295572 | chr5:152281235-152281236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs145226647 | chr5:152281261-152281262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181096549 | chr5:152281287-152281288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs147181776 | chr5:152281293-152281294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs200560030 | chr5:152281294-152281295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs185385436 | chr5:152281368-152281369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs555147048 | chr5:152281377-152281378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs376625672 | chr5:152281383-152281384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573571355 | chr5:152281397-152281398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs11745666 | chr5:152281401-152281402 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs374971647 | chr5:152281404-152281405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552536330 | chr5:152281419-152281420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs79067642 | chr5:152281421-152281422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs545076172 | chr5:152281429-152281430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs113244190 | chr5:152281457-152281458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs566361773 | chr5:152281525-152281526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs575300541 | chr5:152281545-152281546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs543622296 | chr5:152281546-152281547 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Breast cancer | 17603634 | CNVD |
Crohn''s disease | 20106866 | CNVD |
Breast cancer | 20409316 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Deafness | 19353646 | CNVD |
Developmental delay | 19353646 | CNVD |
dysmorphism | 19353646 | CNVD |
feeding difficulties | 19353646 | CNVD |
strabismus | 19353646 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:152279800-152280200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:152279800-152280600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr5:152279800-152280800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr5:152280000-152280600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr5:152280000-152280800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr5:152281200-152282200 | Enhancers | Liver | Liver |
7 | chr5:152282200-152287000 | Weak transcription | Liver | Liver |
8 | chr5:152287000-152287400 | Active TSS | Pancreatic Islets | Pancreatic Islet |
9 | chr5:152287000-152287600 | Active TSS | Liver | Liver |
10 | chr5:152287400-152287600 | Flanking Active TSS | Pancreatic Islets | Pancreatic Islet |
11 | chr5:152287600-152287800 | Flanking Active TSS | Liver | Liver |
12 | chr5:152287800-152288000 | Enhancers | Liver | Liver |
13 | chr5:152289600-152289800 | Enhancers | Liver | Liver |
14 | chr5:152304600-152306000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr5:152305600-152305800 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr5:152306400-152306800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
17 | chr5:152307600-152308000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
18 | chr5:152308000-152309400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
19 | chr5:152309400-152310000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
20 | chr5:152312400-152313000 | Enhancers | Cortex derived primary cultured neurospheres | brain |